Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department
John R. Richards
Journal of Emergency Medicine (2018) Vol. 54, Iss. 3, pp. 354-363
Closed Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings
Deborah S. Hasin, Dvora Shmulewitz, Aaron L. Sarvet
The American Journal of Drug and Alcohol Abuse (2019) Vol. 45, Iss. 6, pp. 623-643
Open Access | Times Cited: 200
Review of Health Consequences of Electronic Cigarettes and the Outbreak of Electronic Cigarette, or Vaping, Product Use-Associated Lung Injury
Dazhe Cao, Kim Aldy, Stephanie Hsu, et al.
Journal of Medical Toxicology (2020) Vol. 16, Iss. 3, pp. 295-310
Open Access | Times Cited: 159
Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE‐4): Alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department
Bjug Borgundvaag, Fernanda Bellolio, Isabelle Miles, et al.
Academic Emergency Medicine (2024) Vol. 31, Iss. 5, pp. 425-455
Open Access | Times Cited: 9
Cannabis use during pregnancy and postpartum
Sophia Badowski, Graeme N. Smith
Canadian Family Physician (2020) Vol. 66, Iss. 2, pp. 98-103
Closed Access | Times Cited: 63
Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms
Marieka V. DeVuono, Linda A. Parker
Cannabis and Cannabinoid Research (2020) Vol. 5, Iss. 2, pp. 132-144
Open Access | Times Cited: 58
TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids
Kathleen Louis-Gray, Srinivasan Tupal, Louis S. Premkumar
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10016-10016
Open Access | Times Cited: 32
The Association between Cannabis Product Characteristics and Symptom Relief
Sarah S. Stith, Jacob M. Vigil, Franco Brockelman, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 50
A review of the anesthetic implications of marijuana use
John C. Alexander, Girish P. Joshi
Baylor University Medical Center Proceedings (2019) Vol. 32, Iss. 3, pp. 364-371
Open Access | Times Cited: 45
Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature
Guillermo Burillo–Putze, John R. Richards, Consuelo Rodríguez‐Jiménez, et al.
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 6, pp. 693-702
Closed Access | Times Cited: 21
Cannabis Hyperemesis Syndrome in Youth: Clinical Insights and Public Health Implications
Jamie A. Seabrook, Mary Seabrook, Jason Gilliland
International Journal of Environmental Research and Public Health (2025) Vol. 22, Iss. 4, pp. 633-633
Open Access
Cannabinoid Hyperemesis Syndrome: Definition, Pathophysiology, Clinical Spectrum, Insights into Acute and Long-Term Management
Mahesh Gajendran, Joshua Sifuentes, Mohammad Bashashati, et al.
Journal of Investigative Medicine (2020) Vol. 68, Iss. 8, pp. 1309-1316
Open Access | Times Cited: 30
Changes in Emergency Department Encounters for Vomiting After Cannabis Legalization in Colorado
George Sam Wang, Christine Buttorff, Asa Wilks, et al.
JAMA Network Open (2021) Vol. 4, Iss. 9, pp. e2125063-e2125063
Open Access | Times Cited: 26
Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence
Christopher N. Andrews, Renata Rehak, Matthew Woo, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 56, Iss. 11-12, pp. 1532-1542
Closed Access | Times Cited: 17
The emergency department care of the cannabis and synthetic cannabinoid patient: a narrative review
Kevin M. Takakuwa, Raquel M. Schears
International Journal of Emergency Medicine (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Cannabinoid drugs against chemotherapy-induced adverse effects: focus on nausea/vomiting, peripheral neuropathy and chemofog in animal models
Ana Bagüés, Yolanda López‐Tofiño, Alvaro Llorente‐Berzal, et al.
Behavioural Pharmacology (2022) Vol. 33, Iss. 2&3, pp. 105-129
Closed Access | Times Cited: 15
Efficacy of Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review
Sean McConachie, Ryan Caputo, Sheila M. Wilhelm, et al.
Annals of Pharmacotherapy (2019) Vol. 53, Iss. 11, pp. 1145-1152
Closed Access | Times Cited: 23
Cannabis use is associated with a small increase in the risk of postoperative nausea and vomiting: a retrospective machine-learning causal analysis
Wendy Suhre, Vikas N. O’Reilly-Shah, Wil Van Cleve
BMC Anesthesiology (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 20
Anesthesia for Patients Who Self-Report Cannabis (Marijuana) Use Before Esophagogastroduodenoscopy: A Retrospective Review.
Daniel D King, Scott A. Stewart, Angela Collins‐Yoder, et al.
(2021) Vol. 89, Iss. 3, pp. 205-212
Closed Access | Times Cited: 16
Rare but relevant: Cannabinoid hyperemesis syndrome
Daniel Stjepanović, Jennifer L. Kirkman, Wayne Hall
Addiction (2024)
Closed Access | Times Cited: 2
Burden of Comorbidities in Hospitalizations for Cannabis Use-associated Intractable Vomiting during Post-legalization Period
Sowmya Madireddy, Rikinkumar S. Patel, Virendrasinh Ravat, et al.
Cureus (2019)
Open Access | Times Cited: 19
Acute Kidney Injury (AKI) in Young Synthetic Cannabinoids Abusers
Stefano D’Errico, Martina Zanon, Davide Radaelli, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1936-1936
Open Access | Times Cited: 10
Emerging Role of Aprepitant in Cannabis Hyperemesis Syndrome
Swetha Parvataneni, Lionel Varela, Sireesha M Vemuri-Reddy, et al.
Cureus (2019)
Open Access | Times Cited: 16
Burden of Persistent Vomiting With Cannabis Use Disorder: Report From 55,549 Hospitalizations in the United States
Rikinkumar S. Patel, Jaiminkumar Patel, Paul Rahul Jaladi, et al.
Psychosomatics (2019) Vol. 60, Iss. 6, pp. 549-555
Open Access | Times Cited: 16
Topical capsaicin for the treatment of cannabinoid hyperemesis syndrome, a systematic review and meta-analysis
Ali Pourmand, Gabriel Esmailian, Maryann Mazer‐Amirshahi, et al.
The American Journal of Emergency Medicine (2021) Vol. 43, pp. 35-40
Closed Access | Times Cited: 13
Management of Cannabinoid Hyperemesis Syndrome: Focus on Capsaicin
Janice L. Stumpf, Lauren D. Williams
Journal of Pharmacy Practice (2020) Vol. 34, Iss. 5, pp. 786-793
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top